Skip to content
Library Home
Start Over
Research Databases
E-Journals
Course Reserves
Library Home
Login to library account
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Language
Library Catalog
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Find
Advanced Search
|
Browse
|
Search Tips
Developing biomarker-based too...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary / Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum.
Saved in:
Bibliographic Details
Main Author:
Patlak, Margie
Corporate Authors:
National Cancer Policy Forum (U.S.)
,
United States. Department of Health and Human Services
Other Authors:
Nass, Sharyl J.
Format:
eBook
Language:
English
Published:
Washington, D.C. :
National Academies Press,
©2006.
Subjects:
Tumor markers
>
Congresses.
MEDICAL
>
Oncology.
HEALTH & FITNESS
>
Diseases
>
Cancer.
Tumor markers
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Online Access:
Click for online access
Holdings
Description
Table of Contents
Similar Items
Staff View
Table of Contents:
Cover
Reviewers
Contents
Introduction
Overview of Technologies Used to Discover Cancer Biomarkers
Genomics, Proteomics, and Metabolomics
Molecular Imaging
Meeting the Technical Challenges of Biomarker Validation and Qualification
Coordinating the Development of Biomarkers and Targeted Therapies
Therapeutics Industry Perspective
Diagnostics Industry Perspective
NCI Perspective
Clinical Investigator Perspective
Biomarker Development and Regulatory Oversight
FDA Critical Path Initiative
Oversight of Diagnostic Tests
Designing Clinical Studies of Biomarkers
Assessment and Adoption of Biomarker-Based Technologies
Federal Programs for Technology Assessment
Insurance Coverage Decisions and Practice Guidelines
CMS Coverage of Biomarkers
Economic Impact of Biomarkers
Cost-Effectiveness Analysis
The Value of Information and Research
Technology Assessment in the Private Sector
Clinical Development Strategies for Biomarker Utilization Discussion
Strategies for Implementing Standardized Biorepositories Discussion
Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion
Strategies to Develop Biomarkers for Early Detection Discussion
Mechanisms for Developing an Evidence Base Discussion
Evaluation of Evidence in Decision Making Discussion
Incorporating Biomarker Evidence Into Clinical Practice Discussion
Acronyms
Glossary
References
Appendixes
Appendix A Workshop Agenda
Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants
Last Page.
Similar Items
Cancer biomarkers
Published: (2011)
Cancer biomarkers : analytical techniques for discovery
by: Hamdan, Mahmoud, 1947-
Published: (2007)
Biomarkers of the tumor microenvironment
Published: (2022)
Cancer biomarkers : the promises and challenges of improving detection and treatment
Published: (2007)
Kallikrein-related peptidases : Novel Cancer-Related Biomarkers.
by: Schmitt, Manfred
Published: (2012)